Cargando…
Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis
BACKGROUND: Duchenne muscular dystrophy (DMD) is characterized by the absence of the cytoskeletal protein dystrophin, muscle wasting, increased transforming growth factor type beta (TGF-β) signaling, and fibrosis. At the present time, the only clinically validated treatments for DMD are glucocortico...
Autores principales: | Cabrera, Daniel, Gutiérrez, Jaime, Cabello-Verrugio, Claudio, Morales, Maria Gabriela, Mezzano, Sergio, Fadic, Ricardo, Casar, Juan Carlos, Hancke, Juan L, Brandan, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021597/ https://www.ncbi.nlm.nih.gov/pubmed/24655808 http://dx.doi.org/10.1186/2044-5040-4-6 |
Ejemplares similares
-
Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease
por: Fadic, Ricardo, et al.
Publicado: (2006) -
Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
por: Cabello-Verrugio, Claudio, et al.
Publicado: (2012) -
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017) -
Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy
por: Pessina, Patrizia, et al.
Publicado: (2014) -
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
por: Morales, María Gabriela, et al.
Publicado: (2016)